NORMAN, OKLA. – Wei R. Chen, Ph.D., Stephenson Chair, Professor and Interim Director of the Stephenson School of Biomedical Engineering, recently organized a session titled Immunophotonics for the Gordon Research Conference Optics and Photonics in Medicine and Biology, held from July 7 to 12, in Lewiston, Maine. Chen also gave an oral presentation, "Localized Immunophotonics for the Treatment of Metastatic Cancers" at the conference.
Chen presented recent results of pre-clinical and clinical results in cancer treatment using their novel immunophotonics technology. Chen’s doctoral students, Trisha Valerio and Coline Furrer, also presented their research results at the conference with posters.
Chen is a pioneer in the field of immunophotonics. His research team is among the first to use biophotonics to induce immune responses to treat late stage, metastatic cancers through the abscopal effect — a phenomenon when a local therapy shrinks not only the targeted tumor, but other untargeted tumors in the body. Specifically, Chen’s team developed a unique combination of laser ablation and a novel immunological drug for the treatment of late-stage, metastatic cancers through local intervention.
Chen is a co-founder of Immunophotonics, Inc. and has served as a member of its Board of Directors since its inception. Immunophotonics has been conducting clinical trials in Europe for the past several years. In 2023, the US Food and Drug Administration approved a phase 1b/2a multiple center clinical trial for late-stage patients with colorectal cancer, non-small cell lung cancer, and soft tissue sarcoma, using the novel therapy developed by Chen’s team.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list. For more information about the university, visit ou.edu.
Nearly 100 undergraduate students gathered on the OU-Tulsa campus recently for an exciting introduction to medical school.
Jonas Nursing, a leading supporter of doctoral nursing education in the U.S., and the American Association of Colleges of Nursing, announced that Caitlin Dressler and Catherine Harris, B.S.-Ph.D. students in the Fran and Earl Ziegler College of Nursing at the University of Oklahoma, have been selected as Jonas Scholars for the program’s current cohort.
Min Li, Ph.D., a George Lynn Cross Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma College of Medicine and Associate Director for Global Oncology at OU Health Stephenson Cancer Center, will receive the 2024 Palade Prize from the International Association of Pancreatology.